Ticker Launch
Sign inTry it free

SPAC · Merger completed

Priveterra Acquisition Corp.

Business combination with AEON Biopharma, Inc.

Priveterra Acquisition Corp. is a blank-check company (SPAC) that raised $240M in its initial public offering on Feb 11, 2021, listing on Nasdaq Capital Market. It completed its business combination with AEON Biopharma, Inc. on Jul 21, 2023; the combined company is AEON Biopharma, Inc. (AEON). Credit Suisse led the IPO, with Banc of America and Deutsche Bank. White & Case advised the SPAC and Davis Polk advised the underwriters on the IPO.

Status
Merger completed
IPO date
Feb 11, 2021
IPO size
$240M
IPO exchange
Nasdaq Capital Market
Target
AEON Biopharma, Inc. (Old AEON)
Announced
Dec 13, 2022
Closed
Jul 21, 2023
Combined company
AEON Biopharma, Inc. (AEON)
IPO underwriters
Credit Suisse, Banc of America, Deutsche Bank, Fresenius Medical Care AG, Renal Care, Warburg Pincus, AMN Healthcare Services, Fisher & Paykel Healthcare, Cross Country Healthcare, Symmetry Medical and Strathspey Crown Holdings
SPAC counsel (IPO)
White & Case
Underwriters' counsel (IPO)
Davis Polk

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2023